Monte Carlo bone marrow dosimetry in radioligand therapy using patient-specific marrow and lesion localization from quantitative 99mTc-sulfur colloid and 177Lu-PSMA-617 SPECT/CT

被引：0
|
作者：
Peterson, Avery [1 ]
Wilderman, Scott [2 ]
Wong, Ka Kit [2 ]
Frey, Kirk [2 ]
Dewaraja, Yuni [2 ]
机构：
[1] Univ Michigan, Wayne State Univ, Ann Arbor, MI USA
[2] Univ Michigan, Ann Arbor, MI USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P162
引用
收藏
页数：4
相关论文
共 16 条
  • [1] Bone Marrow Dosimetry in Radioligand Therapy using AI-Enabled Whole Body Spongiosa Segmentation and Complementary Marrow/Lesion Maps from 99mTc-Sulfur Colloid SPECT/CT and [68Ga]Ga-PSMA-11 PET/CT
    Peterson, A.
    Wilderman, S. J.
    Blakkisrud, J.
    Wong, K.
    Frey, K. A.
    Dewaraja, Y. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S189 - S189
  • [2] Multi-Cycle 177Lu-PSMA-617 Radioligand Therapy Dosimetry Results from a Pilot SPECT/CT Study
    Fitzpatrick, Kellen
    Wong, Ka Kit
    Niedbala, Jeremy
    Roseland, Molly
    Viglianti, Benjamin
    Piert, Morand
    Frey, Kirk
    Dewaraja, Yuni
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [3] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Mahmoudi, Elahe
    Pirayesh, Elahe
    Deevband, Mohammad Reza
    Amoui, Mahasti
    Rad, Mehrdad Ghorbani
    Ghorbani, Mahdi
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (05) : 237 - 244
  • [4] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Elahe Mahmoudi
    Elahe Pirayesh
    Mohammad Reza Deevband
    Mahasti Amoui
    Mehrdad Ghorbani Rad
    Mahdi Ghorbani
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 237 - 244
  • [5] Estimation of local photon dose to active bone marrow in Lu-177 PSMA PRRT therapy using patient-specific Monte Carlo simulations
    Gosewisch, A.
    Delker, A.
    Vomacka, L.
    Fendler, W. P.
    Brunegraf, A.
    Gildehaus, F. J.
    Mairani, A.
    Parodi, K.
    Bartenstein, P. A.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S754 - S755
  • [6] Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
    Grob, Dagmar
    Prive, Bastiaan M.
    Muselaers, Constantijn H. J.
    Mehra, Niven
    Nagarajah, James
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    EJNMMI PHYSICS, 2024, 11 (01)
  • [7] Bone marrow dosimetry in low volume hormone mHSPC receiving Lu-177-PSMA therapy using SPECT/CT
    Grob, D.
    Prive, B. M.
    Nagarajah, J.
    Konijnenberg, M. W.
    Peters, S. M. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S126 - S126
  • [8] Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
    Dagmar Grob
    Bastiaan M. Privé
    Constantijn H. J. Muselaers
    Niven Mehra
    James Nagarajah
    Mark W. Konijnenberg
    Steffie M. B. Peters
    EJNMMI Physics, 11
  • [9] Patient-specific 3D Monte-Carlo-based bone marrow dosimetry for Lu-177-PSMA therapy and the potential value of Tc-99m-anti-granulocyte antibody SPECT/CT for image-based 3D active bone marrow localisation
    Gosewisch, A.
    Ilhan, H.
    Tattenberg, S.
    Mairani, A.
    Parodi, K.
    Brosch, J.
    Kaiser, L.
    Gildehaus, F.
    Todica, A.
    Ziegler, S.
    Bartenstein, P.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S169 - S170
  • [10] 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT
    Astrid Gosewisch
    Harun Ilhan
    Sebastian Tattenberg
    Andrea Mairani
    Katia Parodi
    Julia Brosch
    Lena Kaiser
    Franz Josef Gildehaus
    Andrei Todica
    Sibylle Ziegler
    Peter Bartenstein
    Guido Böning
    EJNMMI Research, 9
12